Abstract
Pituitary-thyroid function has been studied in heroin addicts. Data have been obtained in 10 male addicts, aged 18-24 years, with histories of addiction to heroin alone lasting from 8 months to 4 years, and in 9 controls matched for sex and age. Basal plasma levels of TSH,T4 and T3 were measured. A TRH stimulation test was done, injecting 500μg of TRH iv as a bolus and assaying TSH levels before the injection and at 30 min intervals up to 2 h afterwards. The results revealed no difference between addicts and controls in basal levels of TSH,T4 and T3. The TRH stimulation test induced a blunted TSH rise in 50% of the cases. The possible mechanism of action of heroin on pituitary-thyroid axis is discussed.
Similar content being viewed by others
References
De Wied D., Van Ree J.M., De Jong W. Narcotic analgesics and the neuroendocrine control of anterior pituitary function. In: Zimmermann E., George R. (Eds.), Narcotics and the hypothalamus. Raven Press, New York, 1974, p. 251.
George R., Kokka N. The effects of narcotics on growth hormone, ACTH and TSH secretion. In: Ford D.H., Clouet D. (Eds.), Tissue responses to addictive drugs. Spectrum Publ. Inc., New York, 1976, p. 527.
Brambilla F., Guerrini. A., Guastalla A., Beretta P., De Maio D. Glucose-insulin metabolism in heroin addicts. Neuropsychobiology 2: 341, 1976.
Brambilla F., Sacchetti E., Brunetta M. Pituitary-gonadal function in heroin addicts. Neuropsychobiology 3: 160, 1977.
Brambilla F., Resele L.F., De Maio D. Gonadotropin response to synthetic gonadotropin-hormone releasing hormone (GnRH) in heroin addicts. Am. J. Psychiatry 136: 314, 1979.
Brambilla F., Cazzullo C.L., Bellodi L., De Maio D., Zanoboni A., Zanoboni-Muciaccia W. Prolactin secretion and response to stimuli in male heroin addicts. Neuropsychobiology, 1979 (in press).
Brambilla F., Zanoboni A., Zanoboni-Muciaccia W., De Maio D., Growth hormone response to thyrotropin-hormone releasing hormone (TRH) and gonadotropin-hormone releasing hormone (GnRH) stimulation in heroin addicts. Neuropsychobiology, 1980 (in press).
Redding T.W., Bowers C.Y., Schally A.V. The effects of morphine and other narcotics on thyroid function in mice. Acta Endocrinol. (Kbh.) 51: 391, 1976.
Bruni J.F., Van Vugt D., Marshall S., Meites J. Effects of naloxone, morphine and metionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sci. 21: 461, 1977.
Samel M. Blocking of the thyrotropic secretion by morphine and chlorpromazine in rats. Arch. Int. Pharmacol. 117: 151, 1958.
George R., Lomax P. The effects of morphine, chlorpromazine and reserpine on the pituitary-thyroid activity in rats. J.Pharmacol. 150: 129, 1965.
Hohlweg V.H., Knappe G., Dorner G. Tierexperimentelle Untersuchungen über den Einfluss von Morphine auf die Gonadotrope und Thyrotrope Hypophysenfunktion. Endokt. Bd. 40: 152, 1961.
Bakke J.L., Lawerence M.L., Bennet J. Late effects of perinatal morphine administration on pituitary-thyroid and gonadal function. Biol. Neonate 23: 59, 1973.
Tolis G., Hickey J., Guyda H. Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid-stimulating hormone in man. J. Clin. Endocrinol. Metab. 41: 797, 1975.
Webster B., Compal J., Cushman P. Increased serum thyroxine levels in euthyroid narcotic addicts. J. Clin. Endocrinol. Metab. 37: 928, 1973.
Cushman P., Kreek M.J. Some endocrinological observations in narcotic addicts. In: Zimmermann E., George R. (Eds.), Narcotic and the hypothalamus. Raven Press, New York, 1974, p. 161.
Blackly P.H. Management of opiate abstinence syndrome. Am. J. Psychiatry 122: 742, 1966.
Odell W.D., Wilberg J.F., Utiger R.D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog. Horm. Res. 23: 47, 1967.
Mitsuma T., Colucci J., Shenkman L., Hollander C.S. Rapid simultaneous RIA for triodothyronine and thyroxine in unextracted serum. Biochem. Biophys. Res. Commun. 46: 2107, 1972.
Spector S., Parker C.W. Morphine: radioimmunoassay. Science 168: 1347, 1970.
Whittingham S. Serological method in autoimmune disease in man. In: Kawapinski J.B.J. (Ed.), Research in immunochemistry and immunobiology. University Park Press, Baltimore, 1972, vol. 1, p. 124
Reichlin S., Martin J.B., Mitnick M.A. The hypothalamus in pituitary-thyroid regulation. Recent Prog. Horm. Res. 28: 229, 1972.
Otsuchi M., Dadoka M., Baba S. Influence of glucocorticoids on TRF-induced TSH response in man. J. Clin. Endocrinol. Metab. 36: 95, 1973.
Cushman P., Bordiner B., Hilton J.G. Hypothalamic-pituitary-adrenal axis in methadone treated heroin addicts. J. Clin. Endocrinol. Metab. 30: 24, 1970.
Ghodse A.H. Evaluation of blood glucose, insulin, growth hormone and cortisol response in heroin addicts. Pahlavi Med. J. 8: 141, 1977.
Ozawa Y., Shishiba Y. Lack of TRH-induced TSH secretion in patients with Klinefelter’s syndrome: a case report. Endocrinol. Jpn. 22: 269, 1975.
Vinik A.I., Kalt W.J., McLaren H., Hendricks S., Pimstone B.L. Fasting blunts the TSH response to synthetic tryrotropin-releasing hormone (TRH). J. Clin. Endocrinol. Metab. 40: 509, 1975.
Czernichow P., Dayzet M.C., Broyer M., Rappoport R. Abnormal TSH and GH response to TSH releasing factor in chronic renal failure. J. Clin. Endocrinol. Metab. 43: 630, 1976.
Loosen P.T., Wilson I.C., Lara P.P., Prange A.J., Pettus C. Treatment of depressive state in alcohol withdrawal syndrome by thyrotropin releasing hormone. Arsneimittelforschung 26: 1164, 1976.
Prange A.J., Upton M.A., Nemeroff C.B., Wilson J.C. The role of hormones in depression. Life Sci. 20: 1305, 1977.
Gold P.W., Goodwin F.K., Wehr T., Rebar R. Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolism. Am. J. Psychiatry 134: 1028, 1977.
Kirkegaard C., Norlem N., Lauridsen U.B., Bjorum N. Prognostic value of thyrotropin releasing hormone stimulation test in endogenous depression. Acta Psychiatr. Scand. 52: 170, 1975.
Gregoire F., Brauman H., De Buck R., Corvillan J. Hormone release in depressed patients before and after recovery. Psychoneuroendocrinology 3: 303, 1977.
Brambilla F., Smeraldi E., Sacchetti E., Negri F., Cocchi D., Müller E. Deranged anterior pituitary responsiveness to hypothalamic hormones in depressed patients. Arch. Gen. Psychiatry 35: 1231, 1978.
Schildkraut J.J. Cutrent status of catecholamine hypothesis of affective disorders. In: Lipton M., Di Mascio A., Killam K.F. (Eds.), Psychopharmacology, a generation of progress. Raven Press, New York, 1978, p. 1223.
Murphy D.L., Campbell I., Costa J.L. Current status of indolamine hypothesis of affective disorders. In: Lipton MA, Di Mascio A., Killam K.F. (Eds.), Psychopharmacology, a generation of progress. Raven Press, New York, 1978, p. 1235.
Simon M., George R., Garcia J. Chronic morphine effects on regional brain amines, growth hormone and corticosterone. Eur. J. Pharmacol. 34: 27, 1975.
Ho A.K.S., Ng L.K., Thoa N.B., Colburn R.W. In vitro interaction of synaptosomal uptake of morphine and biogenic amines. In: Ford. D., Clouet D. (Eds.), Tissue responses to addictive drugs. Spectrum Publ. Inc., New York, 1975, p. 209.
Lal H., Puri S., Volicer L. A comparison between narcotics and neuroleptics: effects on striatal dopamine turnover, cyclic AMP, and adenylate cyclase. In: Ford D., Clouet D. (Eds.), Tissue responses to addictive drugs. Spectrum Publ. Inc., New York, 1975, p. 187.
Puri S.K., Volicer L., Cochin J. Changes in the striatal adenylate cyclase activity following acute and chronic morphine treatment and during withdrawal. J. Neurochem. 27: 1551, 1976.
Lomax P., Kokka N., George R. Thyroid activity following intracerebral injection of morphine in the rat. Neuroendocrinology 6: 146, 1970.
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF03349403.
Rights and permissions
About this article
Cite this article
Brambilla, F., Nobile, P., Zanoboni, A. et al. Effects of chronic heroin addiction on pituitary-thyroid function in man. J Endocrinol Invest 3, 251–255 (1980). https://doi.org/10.1007/BF03348271
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348271